Microsoft: A Critical Point in Valuation Momentum
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
Lipella Pharmaceuticals Inc. (LIPO) Stock Forecast for 2025, 2026, 2027. Lipo Prediction. Sell or Buy?
Updated: May 24, 2025 (08:17)
Sector: HealthcareThe share price of Lipella Pharmaceuticals Inc. (LIPO) now
Are you interested in Lipella Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Lipella Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Lipella Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in Lipella Pharmaceuticals stock? When should I record a loss on Lipella Pharmaceuticals stock? What are analysts' forecasts for Lipella Pharmaceuticals stock? What is the future of Lipella Pharmaceuticals stock? We forecast Lipella Pharmaceuticals stock performance using neural networks based on historical data on Lipella Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Lipella Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Lipella Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Lipella Pharmaceuticals stock
The chart below shows the historical price of Lipella Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Lipella Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is a clinical-stage biotech focused on developing therapies for rare diseases with high unmet needs, including oral lichen planus (OLP) and hemorrhagic cystitis. The company leverages the FDA’s 505(b)(2) pathway to accelerate development, bypassing Phase 1 trials for reformulated drugs. Its lead candidate, LP-310—an oral rinse for OLP affecting 6 million Americans—recently gained FDA Expanded Access Program approval, enabling pre-approval patient access and early revenue potential.
Despite a net loss of $1.44M in Q3 2024, Lipella maintains no debt and reduced administrative costs by 21% YoY. Cash reserves stood at $1.35M as of September 2024, with financing activities raising $1.02M. Near-term catalysts include Phase 2a data for LP-310 (mid-2025) and a Phase 2b trial for bladder therapy LP-10. While financial stability remains a concern due to ongoing R&D expenses, Lipella’s niche focus, orphan drug designations, and recent regulatory progress position it as a high-risk, high-reward opportunity for investors seeking exposure to innovative rare disease therapies.
Lipella Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 3.04 | 2.92 | 3.14 | 7.49 |
| May 27 | 3.09 | 3.04 | 3.15 | 3.72 |
| May 28 | 3.11 | 3.04 | 3.17 | 4.35 |
| May 29 | 3.10 | 3.03 | 3.16 | 4.45 |
| May 30 | 3.13 | 3.02 | 3.18 | 5.23 |
| May 31 | 3.19 | 3.15 | 3.31 | 5.01 |
| Jun 01 | 3.21 | 3.17 | 3.31 | 4.61 |
| Jun 02 | 3.18 | 3.08 | 3.23 | 4.86 |
| Jun 03 | 3.04 | 2.99 | 3.15 | 5.33 |
| Jun 04 | 3.01 | 2.91 | 3.09 | 6.05 |
| Jun 05 | 2.97 | 2.92 | 3.01 | 3.00 |
| Jun 06 | 3.02 | 2.96 | 3.12 | 5.26 |
| Jun 07 | 3.16 | 3.12 | 3.25 | 4.30 |
| Jun 08 | 3.31 | 3.27 | 3.43 | 5.16 |
| Jun 09 | 3.45 | 3.41 | 3.57 | 4.49 |
| Jun 10 | 3.41 | 3.30 | 3.54 | 7.24 |
| Jun 11 | 3.48 | 3.43 | 3.59 | 4.77 |
| Jun 12 | 3.47 | 3.44 | 3.52 | 2.48 |
| Jun 13 | 3.32 | 3.28 | 3.41 | 4.05 |
| Jun 14 | 3.40 | 3.31 | 3.47 | 4.67 |
| Jun 15 | 3.42 | 3.36 | 3.55 | 5.65 |
| Jun 16 | 3.45 | 3.38 | 3.49 | 3.27 |
| Jun 17 | 3.54 | 3.40 | 3.68 | 8.12 |
| Jun 18 | 3.59 | 3.48 | 3.66 | 5.42 |
| Jun 19 | 3.73 | 3.70 | 3.87 | 4.65 |
| Jun 20 | 3.66 | 3.52 | 3.74 | 6.13 |
| Jun 21 | 3.64 | 3.58 | 3.78 | 5.70 |
| Jun 22 | 3.49 | 3.38 | 3.62 | 7.18 |
| Jun 23 | 3.41 | 3.35 | 3.49 | 4.44 |
| Jun 24 | 3.35 | 3.23 | 3.46 | 7.37 |
Lipella Pharmaceuticals Daily Price Targets
Lipella Pharmaceuticals Stock Forecast 05-26-2025.
Forecast target price for 05-26-2025: $3.04.
Positive dynamics for Lipella Pharmaceuticals shares will prevail with possible volatility of 6.970%.
Pessimistic target level: 2.92
Optimistic target level: 3.14
Lipella Pharmaceuticals Stock Forecast 05-27-2025.
Forecast target price for 05-27-2025: $3.09.
Positive dynamics for Lipella Pharmaceuticals shares will prevail with possible volatility of 3.582%.
Pessimistic target level: 3.04
Optimistic target level: 3.15
Lipella Pharmaceuticals Stock Forecast 05-28-2025.
Forecast target price for 05-28-2025: $3.11.
Positive dynamics for Lipella Pharmaceuticals shares will prevail with possible volatility of 4.169%.
Pessimistic target level: 3.04
Optimistic target level: 3.17
Lipella Pharmaceuticals Stock Forecast 05-29-2025.
Forecast target price for 05-29-2025: $3.10.
Negative dynamics for Lipella Pharmaceuticals shares will prevail with possible volatility of 4.258%.
Pessimistic target level: 3.03
Optimistic target level: 3.16
Lipella Pharmaceuticals Stock Forecast 05-30-2025.
Forecast target price for 05-30-2025: $3.13.
Positive dynamics for Lipella Pharmaceuticals shares will prevail with possible volatility of 4.968%.
Pessimistic target level: 3.02
Optimistic target level: 3.18
Lipella Pharmaceuticals Stock Forecast 05-31-2025.
Forecast target price for 05-31-2025: $3.19.
Positive dynamics for Lipella Pharmaceuticals shares will prevail with possible volatility of 4.766%.
Pessimistic target level: 3.15
Optimistic target level: 3.31
LIPO (LIPO) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 3.48 | 2.88 | 4.11 | 29.92 |
| Jul. | 4.29 | 3.69 | 5.04 | 26.83 |
| Aug. | 4.41 | 3.51 | 4.74 | 25.95 |
| Sep. | 4.27 | 3.75 | 5.16 | 27.34 |
| Oct. | 3.12 | 2.61 | 3.42 | 23.81 |
| Nov. | 3.26 | 2.57 | 3.71 | 30.84 |
| Dec. | 3.54 | 2.91 | 4.11 | 29.25 |
Lipella Pharmaceuticals forecast for this year
Lipella Pharmaceuticals Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $3.47732. Pessimistic: $2.88. Optimistic: $4.11
Lipella Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $4.29101. Pessimistic: $3.69. Optimistic: $5.04
Lipella Pharmaceuticals Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $4.40687. Pessimistic: $3.51. Optimistic: $4.74
Lipella Pharmaceuticals Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $4.27466. Pessimistic: $3.75. Optimistic: $5.16
Lipella Pharmaceuticals Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $3.1205. Pessimistic: $2.61. Optimistic: $3.42
Lipella Pharmaceuticals Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $3.26093. Pessimistic: $2.57. Optimistic: $3.71
Lipella Pharmaceuticals Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $3.54463. Pessimistic: $2.91. Optimistic: $4.11
Lipella Pharmaceuticals (LIPO) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.80 | 3.12 | 4.16 | 25.18 |
| Feb | 4.24 | 3.67 | 4.74 | 22.56 |
| Mar | 4.87 | 4.56 | 5.89 | 22.56 |
| Apr | 5.16 | 4.70 | 5.69 | 17.42 |
| May | 4.14 | 3.36 | 4.92 | 31.79 |
| Jun | 3.59 | 3.16 | 3.82 | 17.22 |
| Jul | 3.84 | 3.59 | 4.47 | 19.83 |
| Aug | 3.55 | 3.23 | 3.98 | 18.75 |
| Sep | 3.42 | 2.75 | 3.84 | 28.39 |
| Oct | 3.74 | 3.17 | 4.33 | 26.73 |
| Nov | 4.23 | 3.55 | 5.11 | 30.50 |
| Dec | 3.77 | 3.50 | 4.38 | 20.14 |
Lipella Pharmaceuticals (LIPO) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.88 | 3.53 | 4.48 | 21.08 |
| Feb | 4.20 | 3.69 | 4.93 | 25.04 |
| Mar | 3.64 | 2.92 | 4.44 | 34.21 |
| Apr | 3.18 | 2.46 | 3.67 | 33.04 |
| May | 3.44 | 3.18 | 3.75 | 15.14 |
| Jun | 4.11 | 3.29 | 5.05 | 34.93 |
| Jul | 3.55 | 2.91 | 4.19 | 30.68 |
| Aug | 4.39 | 4.03 | 4.90 | 17.73 |
| Sep | 3.07 | 2.59 | 3.47 | 25.24 |
| Oct | 3.02 | 2.64 | 3.68 | 28.13 |
| Nov | 3.01 | 2.38 | 3.55 | 32.80 |
| Dec | 2.22 | 1.97 | 2.43 | 18.66 |
Lipella Pharmaceuticals information and performance
7800 SUSQUEHANNA ST., SUITE 505, PITTSBURGH, PA, UNITED STATES
Market capitalization of the Lipella Pharmaceuticals Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of LIPO shares in the company outstanding by the market price of one share.
EBITDA of Lipella Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Lipella Pharmaceuticals Stock)
Should I Buy Lipella Pharmaceuticals Shares in 2025 year?
Does Lipella Pharmaceuticals pay dividends?
Which economic sector do Lipella Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as Lipella Pharmaceuticals's shares?
